Core Viewpoint - Fuliwang (688678.SH) plans to transfer 12,970,000 shares, representing 5.00% of its total share capital, to WINWIN OVERSEAS GROUP LIMITED for financial support to the company [1][2]. Group 1: Share Transfer Details - The transfer is initiated by WINWIN, which holds 45.02% of Fuliwang's shares, and the transfer is not conducted through secondary market trading [2][3]. - WINWIN will provide all proceeds from the share transfer, after tax deductions, as financial support to Fuliwang for a minimum of one year [1][2]. - The transfer price will be determined based on the average trading price of the stock over the 20 trading days prior to the invitation date, with a minimum price set at 70% of that average [3]. Group 2: Financial Background - Fuliwang was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 23, 2020, raising a total of 783.47 million yuan (approximately 78.25 million) [3][4]. - The company has raised a total of 1.482 billion yuan (approximately 148.2 million) since its listing [5]. - The proceeds from the initial public offering were intended for projects including a precision metal component manufacturing center and a research and development center [3].

Overview - The report details the inquiry transfer of shares from HomeRun Capital Management Limited to specific institutional investors regarding Hongsoft Technology Co., Ltd. [1][9] Transfer Overview - The total number of shares to be transferred is capped at 8,023,408 shares, representing 2.00% of the total share capital and 6.76% of the shares held by the transferor [2][7] - The transfer is conducted in accordance with the Shanghai Stock Exchange's guidelines for inquiry transfers and placements [2][9] Pricing Mechanism - The minimum transfer price is set at no less than 70% of the average trading price of Hongsoft Technology shares over the 20 trading days prior to May 9, 2025 [3][4] - The final transfer price is determined based on a competitive bidding process, prioritizing subscription price, subscription quantity, and the order of receipt of subscription forms [3][4] Subscription Process - A total of 400 institutional investors received the subscription invitation, including various types of investment firms [6] - During the subscription period, 23 valid subscription forms were received, all of which were accepted [7] Final Transfer Details - The determined transfer price is 38.59 yuan per share, leading to a total transaction amount of 309,623,314.72 yuan for the 8,023,408 shares [7][8] - The final recipients of the shares include 18 investment institutions [8] Compliance and Verification - The inquiry transfer process has been verified as legal and compliant with relevant laws and regulations, ensuring fairness and transparency [9][13] - Both the transferor and the transferees have been assessed for eligibility, confirming that they meet the necessary criteria for participation in the transfer [10][11]

中国国际金融股份有限公司 关于上海仁度生物科技股份有限公司 股东向特定机构投资者询价转让股份的核查报告 CENTRAL CHIEF LIMITED 合计 2,497,691 6.24% 500,000 500,000 1.25% 4.99% 本次转让后，CENTRAL CHIEF LIMITED 持有上市公司股份比例将从 6.24%减少 至 4.99%，持有权益比例降至 5%以下。CENTRAL CHIEF LIMITED 不存在其他一致 行动人。 中国国际金融股份有限公司（以下简称"中金公司""组织券商"）受上海仁度 生物科技股份有限公司（以下简称"仁度生物""公司""上市公司"）股东 CENTRAL CHIEF LIMITED（以下简称"CCF""出让方"）委托，组织实施本次仁 度生物股东向特定机构投资者询价转让（以下简称"本次询价转让"）。 经核查，中金公司就本次询价转让的出让方、受让方是否符合《上海证券交易所 科创板上市公司自律监管指引第 4 号——询价转让和配售》（以下简称"《询价转让和 配售指引》"）要求，本次询价转让的询价、转让过程与结果是否公平、公正，是否符 合《询价转让和配售指引》的规定作出 ...

三超新材（300554）公告，根据2025年5月8日询价申购情况，初步确定的本次询价转让价格为15.68元/ 股。本次询价转让为非公开转让，不会通过集中竞价交易方式进行。受让方通过询价转让受让的股份， 在受让后6个月内不得转让。参与本次询价转让报价的机构投资者家数为10家，涵盖了合格境外投资 者、基金管理公司、私募基金管理人、证券公司等专业机构投资者。参与本次询价转让报价的机构投资 者合计有效认购股份数量为876万股，对应的有效认购倍数为1.55倍。本次询价转让拟转让股份已获全 额认购，初步确定受让方为6家机构投资者，拟受让股份总数为564.72万股。 ...

威腾电气公告，根据2025年5月8日询价申购情况，初步确定的本次询价转让价格为25.95元/股。参与本 次询价转让报价的机构投资者家数为10家，涵盖了基金管理公司、合格境外机构投资者、证券公司、私 募基金管理人等专业机构投资者。参与本次询价转让报价的机构投资者合计有效认购股份数量为540万 股，对应转让底价的有效认购倍数为1.66倍。本次询价转让拟转让股份已获全额认购，初步确定受让方 为5家机构投资者，拟受让股份总数为325.37万股。 ...

中国经济网北京4月30日讯帝奥微(688381.SH)昨日晚间披露公告称，上海沃燕创业投资合伙企业(有限 合伙)、江苏润友投资集团有限公司(以下合称"出让方")拟询价转让股份的总数为3,245,000股，占公司总 股本的比例为1.31%。 帝奥微首次公开发行募集资金总额为262,792.40万元，扣除发行费用后募集资金净额为241,560.20万元。 帝奥微最终募集资金净额比原计划多91,560.20万元。2022年8月17日，帝奥微发布的招股书显示，公司 拟募集资金150,000.00万元，分别用于模拟芯片产品升级及产业化项目、上海研发设计中心建设项目、 南通研发检测中心建设项目、补充流动资金。 帝奥微的保荐机构(主承销商)为中信建投（601066）证券股份有限公司，保荐代表人王志丹、冷鲲，联 席主承销商为太平洋证券股份有限公司。帝奥微发行费用总额21,232.20万元，其中中信建投证券股份有 限公司、太平洋证券股份有限公司获得保荐及承销费用18,081.51万元。 保荐机构依法设立的相关子公司中信建投投资有限公司的跟投比例为帝奥微公开发行股票数量的3%， 跟投股数189.15万股，获配金额(不含新股配售经 ...

《科创板日报》4月21日讯（记者 黄修眉） 适用于科创板的交易方式——询价转让正式落地创业板。 近日，创业板公司安培龙披露股东询价转让计划书，由华泰联合证券负责组织实施，安培龙因此成为创 业板首家使用询价转让的企业。 从询价转让方式在创业板的落地来看，深交所于2023年8月4日就《上市公司自律监管指引第16号——创 业板上市公司股东询价转让和配售方式减持股份（征求意见稿）》向社会公开征求意见；并于2024年5 月24日发布实施《深圳证券交易所上市公司自律监管指引第16号——创业板上市公司股东询价和配售方 式转让股份》。 在这之前，仅有科创板公司股东适用上述两种特殊减持方式。 对于询价转让，巨丰投资首席投资顾问张翠霞表示，"相较传统的集中竞价、协议转让、大宗交易等受 让对象单一的减持方式，众多机构参与的询价转让，对二级市场冲击较小。股东可以在相对平稳、有序 的市场环境中完成减持，避免了集中抛售可能引发的股价大幅波动。" 近300家科创板已适用 业内认为，询价转让方式源于科创板，目前达到了其设计初衷——减少对二级市场股价冲击；同时也证 明了这一方式的合理性——让股份定价更加科学和市场化。询价转让方式最终"源自科创 ...